GLPGF (Lakefront Biotherapeutics NV) Total Equity: $3,761 Mil (As of Mar. 2026)


GLPGF Lakefront Biotherapeutics NV GLPGF
62 GF Score
Price $28.08
GF Value $119.16
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Lakefront Biotherapeutics NV Total Equity?

Lakefront Biotherapeutics NV GLPGF 62 Total Equity is $3,761 Mil as of Mar. 2026. GuruFocus rates GLPGF with a GF Score™ of 62/100 and a GF Value™ of $119.16 (Possible Value Trap). The stock has 4 warning signs investors should review.

Lakefront Biotherapeutics NV's total equity for the quarter that ended in Mar. 2026 was $3,761 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Lakefront Biotherapeutics NV Total Equity Historical Data

* Premium members only.

The historical data trend for Lakefront Biotherapeutics NV's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lakefront Biotherapeutics NV Total Equity Chart

Lakefront Biotherapeutics NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,986.85 2,675.88 3,048.60 3,033.44 3,789.07

Lakefront Biotherapeutics NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,970.70 3,049.39 2,872.02 3,789.07 3,761.12
GLPGF
62GF Score
Lakefront Biotherapeutics NV GLPGF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lakefront Biotherapeutics NV Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Lakefront Biotherapeutics NV's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3988.897-199.824
=3,789

Lakefront Biotherapeutics NV's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=3898.762-137.642
=3,761

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $3,761 Mil mean?
Lakefront Biotherapeutics NV (GLPGF) has a Total Equity of $3,761 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Lakefront Biotherapeutics NV and its competitors.
Is Lakefront Biotherapeutics NV's Total Equity too high?
Lakefront Biotherapeutics NV's current Total Equity is $3,761 Mil. Overall, Lakefront Biotherapeutics NV has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lakefront Biotherapeutics NV's Total Equity compare to VRTX and REGN?
Lakefront Biotherapeutics NV's Total Equity of $3,761 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Lakefront Biotherapeutics NV and its competitors. Lakefront Biotherapeutics NV's current Total Equity is $3,761 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lakefront Biotherapeutics NV stock overvalued right now?
Based on GuruFocus' analysis, Lakefront Biotherapeutics NV (GLPGF) is currently considered Possible Value Trap. The stock's GF Value™ is $119.16, compared to a current price of $28.08 — trading 76.4% below its estimated fair value. The current Total Equity is $3,761 Mil. Lakefront Biotherapeutics NV's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Lakefront Biotherapeutics NV (GLPGF), the current Total Equity is $3,761 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lakefront Biotherapeutics NV (GLPGF) Overvalued in 2026?

Based on GuruFocus' analysis, Lakefront Biotherapeutics NV stock appears to be undervalued. The current stock price of $28.08 is trading 76.4% below its estimated GF Value™ of $119.16. GuruFocus considers Lakefront Biotherapeutics NV to be Possible Value Trap.

Key valuation signals for GLPGF:

  • Total Equity: $3,761 Mil
  • GF Value™: $119.16 vs. price of $28.08 (76.4% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the GLPGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lakefront Biotherapeutics NV Business Description

Address Schalienhoevedreef 20 T, Mechelen, BEL, 2800
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
62GF Score

Get the complete analysis for GLPGF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.08
Price
$119.16
GF Value